DACEPTON sol perf 100 mg/20ml 5 flac 20 ml

7680671250015 CH-67125 N04BC07 01.08.0.

Reimbursement limitations:

DACEPTON.100

Après accord sur la prise en charge des frais par la caisse-maladie suite à la …

DACEPTON sol perf 100 mg/20ml 5 flac 20 ml
DACEPTON sol perf 100 mg/20ml 5 flac 20 ml
DACEPTON sol perf 100 mg/20ml 5 flac 20 ml
1 / 3
google

Details

Product number
6712501
CPT
-
Packaging group
5 x 20 ml
Unit
Durchstechflasche(n)
Composition
apomorphini hydrochloridum hemihydricum 5 mg, natrii chloridum, antiox.: E 223 1 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Dacepton 5 mg/ml, Infusionslösung
Infusionslösung
5 x 20 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/01/2022
Patient information leaflet
Français
17/01/2022
Patient information leaflet
Italien
17/01/2022
Professional SmPC
Allemand
17/01/2022
Professional SmPC
Français
17/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 205.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2023

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
67125
Drug name
Dacepton 5 mg/ml, Infusionslösung
Galenic form
LSPA
ATC Code
N04BC07
Authorization status
Z
Dispensation category
B
First authorization
10/12/2018
Authorization expiration date
31/12/9999
IT number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Packaging details

Description (FR)
DACEPTON sol perf 100 mg/20ml 5 flac 20 ml
Description (DE)
DACEPTON Inf Lös 100 mg/20ml 5 Durchstf 20 ml
Market launch
10/12/2018
Narcotic (BTM)
No